PMID- 36835665
OWN - NLM
STAT- MEDLINE
DCOM- 20230228
LR  - 20230228
IS  - 1422-0067 (Electronic)
IS  - 1422-0067 (Linking)
VI  - 24
IP  - 4
DP  - 2023 Feb 20
TI  - Dendritic Cell and Cancer Therapy.
LID - 10.3390/ijms24044253 [doi]
LID - 4253
AB  - Dendritic cells (DCs) are acknowledged as the most potent professional 
      antigen-presenting cells (APCs), able to induce adaptive immunity and support the 
      innate immune response [...].
FAU - Galati, Domenico
AU  - Galati D
AUID- ORCID: 0000-0001-5613-9149
AD  - Hematology-Oncology and Stem Cell Transplantation Unit, Department of Hematology 
      and Innovative Diagnostic, Istituto Nazionale Tumori-IRCCS-Fondazione "G. 
      Pascale" Napoli, 80131 Napoli, Italy.
FAU - Zanotta, Serena
AU  - Zanotta S
AD  - Hematology-Oncology and Stem Cell Transplantation Unit, Department of Hematology 
      and Innovative Diagnostic, Istituto Nazionale Tumori-IRCCS-Fondazione "G. 
      Pascale" Napoli, 80131 Napoli, Italy.
LA  - eng
PT  - Editorial
DEP - 20230220
PL  - Switzerland
TA  - Int J Mol Sci
JT  - International journal of molecular sciences
JID - 101092791
SB  - IM
MH  - Humans
MH  - *Dendritic Cells
MH  - Adaptive Immunity
MH  - Immunity, Innate
MH  - *Neoplasms
PMC - PMC9968100
COIS- The authors declare no conflicts of interest.
EDAT- 2023/02/26 06:00
MHDA- 2023/03/03 06:00
PMCR- 2023/02/20
CRDT- 2023/02/25 02:58
PHST- 2023/02/08 00:00 [received]
PHST- 2023/02/13 00:00 [revised]
PHST- 2023/02/16 00:00 [accepted]
PHST- 2023/02/25 02:58 [entrez]
PHST- 2023/02/26 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2023/02/20 00:00 [pmc-release]
AID - ijms24044253 [pii]
AID - ijms-24-04253 [pii]
AID - 10.3390/ijms24044253 [doi]
PST - epublish
SO  - Int J Mol Sci. 2023 Feb 20;24(4):4253. doi: 10.3390/ijms24044253.